On 11 February 2026, the Agency transmitted to the Commission the revised summary of the product characteristics of the Union authorisation for the biocidal product ‘C(M)IT/MIT & Glutaraldehyde Formulations’ in all official languages of the Union, covering the administrative and minor changes applied for, in accordance with Article 11(6) and Article 12(6) of Implementing Regulation (EU) No 354/2013.
Recital 6, Regulation (EU) 2026/1311
In forcesince 15 Jun 2026